HLA-DRB1, -DQA1, and -DQB1 subtypes or ACE gene polymorphisms do not seem to be risk markers for severe retinopathy in younger Type 1 diabetic patients

Journal of Diabetes and its Complications

Volumn 18, Issue 1, 2004, Pages 32-36

  Agardh, Elisabet ^a   Gaur, Lakshmi K ^b   Lernmark, Åke ^b   Agardh, Carl David ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ACE gene polymorphism; HLA subtypes; Proliferative retinopathy; Severe nonproliferative retinopathy; Type 1 diabetes

Indexed keywords

HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AUTOANTIBODIES; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INSULIN; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK ASSESSMENT;

EID: 1542723381     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(03)00040-0     Document Type: Article

References (25)

1. Agardh D., Gaur L.K., Agardh E., Landin-Olsson M., Agardh C.D., Lernmark A. HLA-DQB1*0201/0302 is associated with severe retinopathy in patients with IDDM. Diabetologia. 39:1996;1313-1317.
2. Birinci A., Birinci H., Abidinoglu R., Durupinar B., Oge I. Diabetic retinopathy and HLA antigens in type 2 diabetes mellitus. European Journal of Ophthalmology. 12:2002;89-93.
3. Cooper S.M., Roessner K.D., Naito-Hoopes M., Howard D.B., Gaur L.K., Budd R.C. Increased usage of V beta 2 and V beta 6 in rheumatoid synovial fluid T cells. Arthritis and Rheumatism. 37:1994;1627-1636.
4. Cruickshanks K.J., Vadheim C.M., Moss S.E., Roth M.P., Riley W.J., Maclaren N.K., Langfield D., Sparkes R.S., Klein R., Rotter J.I. Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes. 41:1992;879-885.
5. Diabetes Control and Complications Trial Research Group Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes. 46:1997;1829-1839.
6. Early Treatment Diabetic Retinopathy Study Research Group Early photocoagulation for diabetic retinopathy: ETDRS report number 9. Ophthalmology. 98:1991;766-785.
7. Falck A.A., Knip J.M., Ilonen J.S., Laatikainen L.T. Genetic markers in early diabetic retinopathy of adolescents with type I diabetes. Journal of Diabetes and Its Complications. 11:1997;203-207.
8. Falorni A., Grubin C.E., Takei I., Shimada A., Kasuga A., Maruyama T., Ozawa Y., Kasatani T., Saruta T., Li L.et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity. 19:1994;113-125.
9. Fujisawa T., Ikegami H., Kawaguchi Y., Hamada Y., Ueda H., Shintani M., Fukuda M., Ogihara T. Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia. 41:1998;47-53.
10. Graham J., Hagopian W.A., Kockum I., Li L.S., Sanjeevi C.B., Lowe R.M., Schaefer J.B., Zarghami M., Day H.L., Landin-Olsson M., Palmer J.P., Janer-Villanueva M., Hood L., Sundkvist G., Lernmark A., Breslow N., Dahlquist G., Blohme G. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes. 51:2002;1346-1355.
11. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelsen B., Lernmark A. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 37:1994;344-350.
12. Gutierrez C., Vendrell J., Pastor R., Llor C., Aguilar C., Broch M., Richart C. Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism. 46:1997;976-980.
13. Holmquist B., Bunning P., Riordan J.F. A continuous spectrophotometric assay for angiotensin converting enzyme. Analytical Biochemistry. 95:1979;540-548.
14. Klein R., Klein B.E., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Archives of Ophthalmology. 102:1984;520-526.
15. Marre M., Bernadet P., Gallois Y., Savagner F., Guyene T.T., Hallab M., Cambien F., Passa P., Alhenc-Gelas F. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes. 43:1994;384-388.
16. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 16:1988;1215.
17. Nagi D.K., Mansfield M.W., Stickland M.H., Grant P.J. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabetic Medicine. 12:1995;997-1001.
18. Olofsson A., Agardh E., Fex G., Abrahamson M., Agardh C.-D. Lack of relationship between insertion/deletion polymorphism in the angiotensin converting enzyme gene and severe retinopathy in insulin-dependent diabetes mellitus. Diabetes Research. 31:1996;119-129.
19. Quiroz-Mercado H., Suarez-Licona A., Fromow-Guerra J., Lopez-Carasa G., Cardenas-Hernandez R., Ruiz-Morales J.A., Portal-Celhay C., Granados J. Human lymphocyte antigen DR7 protects against proliferative retinopathy with type II diabetes mellitus. Archives of Medical Research. 33:2002;123-127.
20. Rabensteiner D., Abrahamian H., Irsigler K., Hermann K.M., Kiener H.P., Mayer G., Kaider A., Prager R. ACE gene polymorphism and proliferative retinopathy in type 1 diabetes: results of a case-control study. Diabetes Care. 22:1999;1530-1535.
21. Ronca-Testoni S. Direct spectrophotometric assay for angiotensin- converting enzyme in serum. Clinical Chemistry. 29:1983;1093-1096.
22. Tarnow L., Cambien F., Rossing P., Nielsen F.S., Hansen B.V., Lecerf L., Poirier O., Danilov S., Parving H.H. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes. 44:1995;489-494.
23. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., Soubrier F. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. American Journal of Human Genetics. S1:1992;197-205.
24. Wong T.Y., Cruickshank K.J., Klein R., Klein B.E., Moss S.E., Palta M., Riley W.J., Maclaren N.K., Vadheim C.M., Rotter J.I. HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. Ophthalmology. 109:2002;275-281.
25. Zhang L., Krzentowski G., Albert A., Lefebvre P.J. Risk of developing retinopathy in Diabetes Control and Complications Trial in type 1 diabetic patients with good or poor metabolic control. Diabetes Care. 24:2001;1275-1279.